Chromatin remodeler mutations in human cancers: Epigenetic implications

Epigenomics

Volumn 6, Issue 4, 2014, Pages 397-414

  Skulte, Katherine A ^a   Phan, Lisa ^a   Clark, Susan J ^a,b   Taberlay, Phillippa C ^a,b  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

ARID1A; BRG1; BRM; cancer; chromatin remodeling; epigenetics; nucleosome; SNF5; SWI SNF

Indexed keywords

DEOXYRIBONUCLEASE I; HISTONE; PROTEIN SWI; TRANSCRIPTION FACTOR SNF; NONHISTONE PROTEIN; TRANSCRIPTION FACTOR;

CANCER GROWTH; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMOSOME ABERRATION; DNA METHYLATION; EPIGENETICS; GENE MUTATION; GENE STRUCTURE; HISTONE MODIFICATION; HUMAN; MUTATION RATE; NEOPLASM; NUCLEOSOME; REVIEW; ANIMAL; GENETIC EPIGENESIS; GENETICS; MUTATION;

ANIMALS; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMOSOMAL PROTEINS, NON-HISTONE; EPIGENESIS, GENETIC; HUMANS; MUTATION; NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 84908156304     PISSN: 17501911     EISSN: 1750192X     Source Type: Journal    
DOI: 10.2217/epi.14.37     Document Type: Review

References (137)

1. Sharma S, Kelly TK, Jones PA. Epigenetics in cancer. Carcinogenesis 31(1), 27-36 (2010).
2. Taberlay PC, Jones PA. DNA methylation and cancer. Prog. Drug Res. 67, 1-23 (2011).
3. Jones PA, Baylin SB. The epigenomics of cancer. Cell 128(4), 683-692 (2007).
4. Shen H, Laird PW. Interplay between the cancer genome and epigenome. Cell 153(1), 38-55 (2013).
5. You JS, Jones PA. Cancer genetics and epigenetics: two sides of the same coin? Cancer Cell 22(1), 9-20 (2012).
6. Reisman D, Glaros S, Thompson EA. The SWI/SNF complex and cancer. Oncogene 28(14), 1653-1668 (2009).
7. Staynov DZ, Proykova YG. Topological constraints on the possible structures of the 30 nm chromatin fibre. Chromosoma 117(1), 67-76 (2008).
8. Allfrey VG, Littau VC, Mirsky AE. On the role of histones in regulation of ribonucleic acid synthesis in the cell nucleus. Proc. Natl Acad. Sci. USA 49, 414-421 (1963).
9. Hawkins RD, Larjo A, Tripathi SK et al. Global chromatin state analysis reveals lineage-specific enhancers during the initiation of human T helper 1 and T helper 2 cell polarization. Immunity 38(6), 1271-1284 (2013).
10. Heintzman ND, Hon GC, Hawkins RD et al. Histone modifications at human enhancers reflect global cell-typespecific gene expression. Nature 459(7243), 108-112 (2009).
11. Heinz S, Benner C, Spann N et al. Simple combinations of lineage-determining transcription factors prime cisregulatory elements required for macrophage and B cell identities. Mol. Cell 38(4), 576-589 (2010).
12. Gifford CA, Ziller MJ, Gu H et al. Transcriptional and epigenetic dynamics during specification of human embryonic stem cells. Cell 153(5), 1149-1163 (2013).
13. Stopka T, Skoultchi AI. The ISWI ATPase Snf2h is required for early mouse development. Proc. Natl Acad. Sci. USA 100(24), 14097-14102 (2003).
14. Curtis CD, Griffin CT. The chromatin-remodeling enzymes BRG1 and CHD4 antagonistically regulate vascular Wnt signaling. Mol. Cell Biol. 32(7), 1312-1320 (2012).
15. Ingram KG, Curtis CD, Silasi-Mansat R, Lupu F, Griffin CT. The NuRD chromatin-remodeling enzyme CHD4 promotes embryonic vascular integrity by transcriptionally regulating extracellular matrix proteolysis. PLoS Genet. 9(12), e1004031 (2013).
16. Neuman SD, Ihry RJ, Gruetzmacher KM, Bashirullah A. INO80-dependent regression of ecdysone-induced transcriptional responses regulates developmental timing in Drosophila. Dev. Biol. 387(2), 229-239 (2014).
17. Chen T, Dent SY. Chromatin modifiers and remodellers: regulators of cellular differentiation. Nat. Rev. Genet. 15(2), 93-106 (2014).
18. Nord AS, Blow MJ, Attanasio C et al. Rapid and pervasive changes in genome-wide enhancer usage during mammalian development. Cell 155(7), 1521-1531 (2013).
19. Clapier CR, Cairns BR. The biology of chromatin remodeling complexes. Annu. Rev. Biochem. 78, 273-304 (2009).
20. Wilson BG, Roberts CW. SWI/SNF nucleosome remodellers and cancer. Nat. Rev. Cancer 11(7), 481-492 (2011).
21. Chen L, Cai Y, Jin J et al. Subunit organization of the human INO80 chromatin remodeling complex: an evolutionarily conserved core complex catalyzes ATP-dependent nucleosome remodeling. J. Biol. Chem. 286(13), 11283-11289 (2011).
22. Jin J, Cai Y, Yao T et al. A mammalian chromatin remodeling complex with similarities to the yeast INO80 complex. J. Biol. Chem. 280(50), 41207-41212 (2005).
23. Leroy G, Loyola A, Lane WS, Reinberg D. Purification and characterization of a human factor that assembles and remodels chromatin. J. Biol. Chem. 275(20), 14787-14790 (2000).
24. Loyola A, Huang JY, Leroy G et al. Functional analysis of the subunits of the chromatin assembly factor RSF. Mol. Cell Biol. 23(19), 6759-6768 (2003).
25. Vignali M, Hassan AH, Neely KE, Workman JL. ATPdependent chromatin-remodeling complexes. Mol. Cell Biol. 20(6), 1899-1910 (2000).
26. Becker PB, Workman JL. Nucleosome remodeling and epigenetics. Cold Spring Harb. Perspect. Biol. 5(9), pii a017905 (2013).
27. Flaus A, Owen-Hughes T. Mechanisms for nucleosome mobilization. Biopolymers 68(4), 563-578 (2003).
28. Kulic IM, Schiessel H. Chromatin dynamics: nucleosomes go mobile through twist defects. Phys. Rev. Lett. 91(14), 148103 (2003).
29. Richmond TJ, Davey CA. The structure of DNA in the nucleosome core. Nature 423(6936), 145-150 (2003).
30. Langst G, Becker PB. Nucleosome remodeling: one mechanism, many phenomena? Biochim. Biophys. Acta 1677(1-3), 58-63 (2004).
31. Lia G, Praly E, Ferreira H et al. Direct observation of DNA distortion by the RSC complex. Mol. Cell 21(3), 417-425 (2006).
32. Lorch Y, Davis B, Kornberg RD. Chromatin remodeling by DNA bending, not twisting. Proc. Natl Acad. Sci. USA 102(5), 1329-1332 (2005).
33. Saha A, Wittmeyer J, Cairns BR. Mechanisms for nucleosome movement by ATP-dependent chromatin remodeling complexes. Results Probl. Cell Differ. (41) 127-148 (2006).
34. Narlikar GJ, Sundaramoorthy R, Owen-Hughes T. Mechanisms and functions of ATP-dependent chromatinremodeling enzymes. Cell 154(3), 490-503 (2013).
35. Schwanbeck R, Xiao H, Wu C. Spatial contacts and nucleosome step movements induced by the NURF chromatin remodeling complex. J. Biol. Chem. 279(38), 39933-39941 (2004).
36. Blosser TR, Yang JG, Stone MD, Narlikar GJ, Zhuang X. Dynamics of nucleosome remodelling by individual ACF complexes. Nature 462(7276), 1022-1027 (2009).
37. Deindl S, Hwang WL, Hota SK et al. ISWI remodelers slide nucleosomes with coordinated multi-base-pair entry steps and single-base-pair exit steps. Cell 152(3), 442-452 (2013).
38. Bruno M, Flaus A, Stockdale C, Rencurel C, Ferreira H, Owen-Hughes T. Histone H2A/H2B dimer exchange by ATP-dependent chromatin remodeling activities. Mol. Cell 12(6), 1599-1606 (2003).
39. Dechassa ML, Sabri A, Pondugula S et al. SWI/SNF has intrinsic nucleosome disassembly activity that is dependent on adjacent nucleosomes. Mol. Cell 38(4), 590-602 (2010).
40. Ichinose H, Garnier JM, Chambon P, Losson R. Liganddependent interaction between the estrogen receptor and the human homologues of SWI2/SNF2. Gene 188(1), 95-100 (1997).
41. King HA, Trotter KW, Archer TK. Chromatin remodeling during glucocorticoid receptor regulated transactivation. Biochim. Biophys. Acta 1819(7), 716-726 (2012).
42. Lessard J, Wu JI, Ranish JA et al. An essential switch in subunit composition of a chromatin remodeling complex during neural development. Neuron 55(2), 201-215 (2007).
43. Lickert H, Takeuchi JK, Von Both I et al. Baf60c is essential for function of BAF chromatin remodelling complexes in heart development. Nature 432(7013), 107-112 (2004).
44. Morris SA, Baek S, Sung MH et al. Overlapping chromatinremodeling systems collaborate genome wide at dynamic chromatin transitions. Nat. Struct. Mol. Biol. 21(1), 73-81 (2014).
45. Gao H, Lukin K, Ramirez J, Fields S, Lopez D, Hagman J. Opposing effects of SWI/SNF and Mi-2/NuRD chromatin remodeling complexes on epigenetic reprogramming by EBF and Pax5. Proc. Natl Acad. Sci. USA 106(27), 11258-11263 (2009).
46. Moshkin YM, Chalkley GE, Kan TW et al. Remodelers organize cellular chromatin by counteracting intrinsic histone-DNA sequence preferences in a class-specific manner. Mol. Cell Biol. 32(3), 675-688 (2012).
47. Neely KE, Workman JL. The complexity of chromatin remodeling and its links to cancer. Biochim. Biophys. Acta 1603(1), 19-29 (2002).
48. Lai AY, Wade PA. Cancer biology and NuRD. a multifaceted chromatin remodelling complex. Nat. Rev. Cancer 11(8), 588-596 (2011).
49. Phelan ML, Sif S, Narlikar GJ, Kingston RE. Reconstitution of a core chromatin remodeling complex from SWI/SNF subunits. Mol. Cell 3(2), 247-253 (1999).
50. Kim Y, Fedoriw AM, Magnuson T. An essential role for a mammalian SWI/SNF chromatin-remodeling complex during male meiosis. Development 139(6), 1133-1140 (2012).
51. Reisman DN, Strobeck MW, Betz BL et al. Concomitant down-regulation of BRM and BRG1 in human tumor cell lines: differential effects on RB-mediated growth arrest vs CD44 expression. Oncogene 21(8), 1196-1207 (2002).
52. Chandler RL, Brennan J, Schisler JC, Serber D, Patterson C, Magnuson T. ARID1a-DNA interactions are required for promoter occupancy by SWI/SNF. Mol. Cell Biol. 33(2), 265-280 (2013).
53. Bultman S, Gebuhr T, Yee D et al. A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes. Mol. Cell 6(6), 1287-1295 (2000).
54. Sumi-Ichinose C, Ichinose H, Metzger D, Chambon P. SNF2beta-BRG1 is essential for the viability of F9 murine embryonal carcinoma cells. Mol. Cell Biol. 17(10), 5976-5986 (1997).
55. Smith-Roe SL, Bultman SJ. Combined gene dosage requirement for SWI/SNF catalytic subunits during early mammalian development. Mamm. Genome 24(1-2), 21-29 (2013).
56. Strobeck MW, Reisman DN, Gunawardena RW et al. Compensation of BRG-1 function by Brm: insight into the role of the core SWI-SNF subunits in retinoblastoma tumor suppressor signaling. J. Biol. Chem. 277(7), 4782-4789 (2002).
57. Oike T, Ogiwara H, Tominaga Y et al. A synthetic lethalitybased strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1. Cancer Res. 73(17), 5508-5518 (2013).
58. Flores-Alcantar A, Gonzalez-Sandoval A, Escalante-Alcalde D, Lomeli H. Dynamics of expression of ARID1A and ARID1B subunits in mouse embryos and in cells during the cell cycle. Cell Tissue Res. 345(1), 137-148 (2011).
59. Wang X, Nagl NG, Wilsker D et al. Two related ARID family proteins are alternative subunits of human SWI/SNF complexes. Biochem. J. 383(Pt 2), 319-325 (2004).
60. Xu F, Flowers S, Moran E. Essential role of ARID2 proteincontaining SWI/SNF complex in tissue-specific gene expression. J. Biol. Chem. 287(7), 5033-5041 (2012).
61. Nagl NG, Jr., Wang X, Patsialou A, Van Scoy M, Moran E. Distinct mammalian SWI/SNF chromatin remodeling complexes with opposing roles in cell-cycle control. EMBO J. 26(3), 752-763 (2007).
62. Yan Z, Wang Z, Sharova L et al. BAF250B-associated SWI/ SNF chromatin-remodeling complex is required to maintain undifferentiated mouse embryonic stem cells. Stem Cells 26(5), 1155-1165 (2008).
63. Kia SK, Gorski MM, Giannakopoulos S, Verrijzer CP. SWI/SNF mediates polycomb eviction and epigenetic reprogramming of the INK4b-ARF-INK4a locus. Mol. Cell Biol. 28(10), 3457-3464 (2008).
64. Tamkun JW, Deuring R, Scott MP et al. Brahma: a regulator of Drosophila homeotic genes structurally related to the yeast transcriptional activator SNF2/SWI2. Cell 68(3), 561-572 (1992).
65. Wilson BG, Wang X, Shen X et al. Epigenetic antagonism between polycomb and SWI/SNF complexes during oncogenic transformation. Cancer Cell 18(4), 316-328 (2010).
66. Barrales RR, Korber P, Jimenez J, Ibeas JI. Chromatin modulation at the FLO11 promoter of Saccharomyces cerevisiae by HDAC and Swi/Snf complexes. Genetics 191(3), 791-803 (2012).
67. Kim JH, Saraf A, Florens L, Washburn M, Workman JL. Gcn5 regulates the dissociation of SWI/SNF from chromatin by acetylation of Swi2/Snf2. Genes Dev. 24(24), 2766-2771 (2010).
68. Mitra D, Parnell EJ, Landon JW, Yu Y, Stillman DJ. SWI/SNF binding to the HO promoter requires histone acetylation and stimulates TATA-binding protein recruitment. Mol. Cell Biol. 26(11), 4095-4110 (2006).
69. Zhang HS, Gavin M, Dahiya A et al. Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF. Cell 101(1), 79-89 (2000).
70. Ogiwara H, Ui A, Otsuka A et al. Histone acetylation by CBP and p300 at double-strand break sites facilitates SWI/SNF chromatin remodeling and the recruitment of non-homologous end joining factors. Oncogene 30(18), 2135-2146 (2011).
71. Zhao J, Liu C, Zhao Z. ARID1A. a potential prognostic factor for breast cancer. Tumour Biol. (2014).
72. Yokoyama Y, Matsushita Y, Shigeto T, Futagami M, Mizunuma H. Decreased ARID1A expression is correlated with chemoresistance in epithelial ovarian cancer. J. Gynecol. Oncol. 25(1), 58-63 (2014).
73. Song S, Walter V, Karaca M et al. Gene silencing associated with SWI/SNF complex loss during NSCLC development. Mol. Cancer Res. 12(4), 560-570 (2014).
74. Buscarlet M, Krasteva V, Ho L et al. Essential role of BRG, the ATPase subunit of BAF chromatin remodeling complexes, in leukemia maintenance. Blood 123(11), 1720-1728 (2014).
75. Yan HB, Wang XF, Zhang Q et al. Reduced expression of the chromatin remodeling gene ARID1A enhances gastric cancer cell migration and invasion via downregulation of E-cadherin transcription. Carcinogenesis 35(4) 867-876 (2013).
76. Shi J, Whyte WA, Zepeda-Mendoza CJ et al. Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation. Genes Dev. 27(24), 2648-2662 (2013).
77. Shain AH, Pollack JR. The spectrum of SWI/SNF mutations, ubiquitous in human cancers. PloS One 8(1), e55119 (2013).
78. Romero OA, Torres-Diz M, Pros E et al. MAX inactivation in small-cell lung cancer disrupts the MYC-SWI/SNF programs and is synthetic lethal with BRG1. Cancer Discov. 4(3), 292-303 (2013).
79. Oike T, Ogiwara H, Nakano T, Yokota J, Kohno T. Inactivating mutations in SWI/SNF chromatin remodeling genes in human cancer. Jpn J. Clin. Oncol. 43(9), 849-855 (2013).
80. Mao TL, Ardighieri L, Ayhan A et al. Loss of ARID1A expression correlates with stages of tumor progression in uterine endometrioid carcinoma. Am. J. Surg. Pathol. 37(9), 1342-1348 (2013).
81. Cho H, Kim JS, Chung H, Perry C, Lee H, Kim JH. Loss of ARID1A/BAF250a expression is linked to tumor progression and adverse prognosis in cervical cancer. Hum. Pathol. 44(7), 1365-1374 (2013).
82. Bosse T, Ter Haar NT, Seeber LM et al. Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations, TP53 and microsatellite instability in endometrial cancer. Mod. Pathol. 26(11), 1525-1535 (2013).
83. Bai J, Mei P, Zhang C et al. BRG1 is a prognostic marker and potential therapeutic target in human breast cancer. PloS One 8(3), e59772 (2013).
84. Katagiri A, Nakayama K, Rahman MT et al. Loss of ARID1A expression is related to shorter progression-free survival and chemoresistance in ovarian clear cell carcinoma. Mod. Pathol. 25(2), 282-288 (2012).
85. Roberts CW, Biegel JA. The role of SMARCB1/INI1 in development of rhabdoid tumor. Cancer Biol. Ther. 8(5), 412-416 (2009).
86. Roy DM, Walsh LA, Chan TA. Driver mutations of cancer epigenomes. Protein Cell 5(4), 265-296 (2014).
87. Roberts CW, Orkin SH. The SWI/SNF complex-chromatin and cancer. Nat. Rev. Cancer 4(2), 133-142 (2004).
88. Wilson BG, Helming KC, Wang X et al. Residual complexes containing SMARCA2 (BRM) underlie the oncogenic drive of SMARCA4 (BRG1) mutation. Mol. Cell Biol. 34(6), 1136-1144 (2014).
89. Sun A, Tawfik O, Gayed B et al. Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers. Prostate 67(2), 203-213 (2007).
90. Mckenna ES, Sansam CG, Cho YJ et al. Loss of the epigenetic tumor suppressor SNF5 leads to cancer without genomic instability. Mol. Cell Biol. 28(20), 6223-6233 (2008).
91. Tolstorukov MY, Sansam CG, Lu P et al. Swi/Snf chromatin remodeling/tumor suppressor complex establishes nucleosome occupancy at target promoters. Proc. Natl Acad. Sci. USA 110(25), 10165-10170 (2013).
92. He HH, Meyer CA, Shin H et al. Nucleosome dynamics define transcriptional enhancers. Nat. Genet. 42(4), 343-347 (2010).
93. Andreu-Vieyra C, Lai J, Berman BP et al. Dynamic nucleosome-depleted regions at androgen receptor enhancers in the absence of ligand in prostate cancer cells. Mol. Cell Biol. 31(23), 4648-4662 (2011).
94. Hu G, Schones DE, Cui K et al. Regulation of nucleosome landscape and transcription factor targeting at tissue-specific enhancers by BRG1. Genome Res. 21(10), 1650-1658 (2011).
95. Li L, Liu D, Bu D et al. Brg1-dependent epigenetic control of vascular smooth muscle cell proliferation by hydrogen sulfide. Biochim. Biophys. Acta 1833(6), 1347-1355 (2013).
96. Bultman SJ, Gebuhr TC, Magnuson T. A Brg1 mutation that uncouples ATPase activity from chromatin remodeling reveals an essential role for SWI/SNF-related complexes in beta-globin expression and erythroid development. Genes Dev. 19(23), 2849-2861 (2005).
97. Harte MT, Obrien GJ, Ryan NM et al. BRD7, a subunit of SWI/SNF complexes, binds directly to BRCA1 and regulates BRCA1-dependent transcription. Cancer Res. 70(6), 2538-2547 (2010).
98. Miranda TB, Voss TC, Sung MH et al. Reprogramming the chromatin landscape: interplay of the estrogen and glucocorticoid receptors at the genomic level. Cancer Res. 73(16), 5130-5139 (2013).
99. Fryer CJ, Archer TK. Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex. Nature 393(6680), 88-91 (1998).
100. Li J, Fu J, Toumazou C, Yoon HG, Wong J. A role of the amino-terminal (N) and carboxyl-terminal (C) interaction in binding of androgen receptor to chromatin. Mol. Endocrinol. 20(4), 776-785 (2006).
101. Ostlund Farrants AK, Blomquist P, Kwon H, Wrange O. Glucocorticoid receptor-glucocorticoid response element binding stimulates nucleosome disruption by the SWI/SNF complex. Mol. Cell Biol. 17(2), 895-905 (1997).
102. Marshall TW, Link KA, Petre-Draviam CE, Knudsen KE. Differential requirement of SWI/SNF for androgen receptor activity. J. Biol. Chem. 278(33), 30605-30613 (2003).
103. Zhang B, Chambers KJ, Faller DV, Wang S. Reprogramming of the SWI/SNF complex for co-activation or co-repression in prohibitin-mediated estrogen receptor regulation. Oncogene 26(50), 7153-7157 (2007).
104. Gorski JJ, James CR, Quinn JE et al. BRCA1 transcriptionally regulates genes associated with the basal-like phenotype in breast cancer. Breast Cancer Res. Treat. 122(3), 721-731 (2010).
105. Mazaris E, Tsiotras A. Molecular pathways in prostate cancer. Nephrourol. Mon. 5(3), 792-800 (2013).
106. Ung M, Ma X, Johnson KC, Christensen BC, Cheng C. Effect of estrogen receptor alpha binding on functional DNA methylation in breast cancer. Epigenetics 9(4), 523-532 (2014).
107. Duong V, Bret C, Altucci L et al. Specific activity of class II histone deacetylases in human breast cancer cells. Mol. Cancer Res. 6(12), 1908-1919 (2008).
108. Feng D, Wu J, Tian Y et al. Targeting of histone deacetylases to reactivate tumour suppressor genes and its therapeutic potential in a human cervical cancer xenograft model. PloS One 8(11), e80657 (2013).
109. Wang G, He J, Zhao J et al. Class I and class II histone deacetylases are potential therapeutic targets for treating pancreatic cancer. PloS One 7(12), e52095 (2012).
110. Shen W, Xu C, Huang W et al. Solution structure of human Brg1 bromodomain and its specific binding to acetylated histone tails. Biochemistry 46(8), 2100-2110 (2007).
111. Luebben WR, Sharma N, Nyborg JK. Nucleosome eviction and activated transcription require p300 acetylation of histone H3 lysine 14. Proc. Natl Acad. Sci. USA 107(45), 19254-19259 (2010).
112. Naidu SR, Love IM, Imbalzano AN, Grossman SR, Androphy EJ. The SWI/SNF chromatin remodeling subunit BRG1 is a critical regulator of p53 necessary for proliferation of malignant cells. Oncogene 28(27), 2492-2501 (2009).
113. Tie F, Banerjee R, Conrad PA, Scacheri PC, Harte PJ. Histone demethylase UTX and chromatin remodeler BRM bind directly to CBP and modulate acetylation of histone H3 lysine 27. Mol. Cell Biol. 32(12), 2323-2334 (2012).
114. Zeisig DT, Bittner CB, Zeisig BB, Garcia-Cuellar MP, Hess JL, Slany RK. The eleven-nineteen-leukemia protein ENL connects nuclear MLL fusion partners with chromatin. Oncogene 24(35), 5525-5532 (2005).
115. Nie Z, Yan Z, Chen EH et al. Novel SWI/SNF chromatin-remodeling complexes contain a mixed-lineage leukemia chromosomal translocation partner. Mol. Cell Biol. 23(8), 2942-2952 (2003).
116. Chodavarapu RK, Feng S, Bernatavichute YV et al. Relationship between nucleosome positioning and DNA methylation. Nature 466(7304), 388-392 (2010).
117. Choi SH, Heo K, Byun HM, An W, Lu W, Yang AS. Identification of preferential target sites for human DNA methyltransferases. Nucleic Acids Res. 39(1), 104-118 (2011).
118. Collings CK, Waddell PJ, Anderson JN. Effects of DNA methylation on nucleosome stability. Nucleic Acids Res. 41(5), 2918-2931 (2013).
119. Jeong S, Liang G, Sharma S et al. Selective anchoring of DNA methyltransferases 3A and 3B to nucleosomes containing methylated DNA. Mol. Cell Biol. 29(19), 5366-5376 (2009).
120. Kelly TK, Liu Y, Lay FD, Liang G, Berman BP, Jones PA. Genome-wide mapping of nucleosome positioning and DNA methylation within individual DNA molecules. Genome Res. 22(12), 2497-2506 (2012).
121. Sharma S, De Carvalho DD, Jeong S, Jones PA, Liang G. Nucleosomes containing methylated DNA stabilize DNA methyltransferases 3A/3B and ensure faithful epigenetic inheritance. PLoS Genet. 7(2), e1001286 (2011).
122. You JS, Kelly TK, De Carvalho DD, Taberlay PC, Liang G, Jones PA. OCT4 establishes and maintains nucleosome-depleted regions that provide additional layers of epigenetic regulation of its target genes. Proc. Natl Acad. Sci. USA 108(35), 14497-14502 (2011).
123. Hinshelwood RA, Melki JR, Huschtscha LI et al. Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning. Hum. Mol. Genet. 18(16), 3098-3109 (2009).
124. Banine F, Bartlett C, Gunawardena R et al. SWI/SNF chromatin-remodeling factors induce changes in DNA methylation to promote transcriptional activation. Cancer Res. 65(9), 3542-3547 (2005).
125. Choi JK. Contrasting chromatin organization of CpG islands and exons in the human genome. Genome Biol. 11(7), R70 (2010).
126. Ndlovu MN, Denis H, Fuks F. Exposing the DNA methylome iceberg. Trends Biochem. Sci. 36(7), 381-387 (2011).
127. Gelfman S, Cohen N, Yearim A, Ast G. DNA-methylation effect on cotranscriptional splicing is dependent on GC architecture of the exon-intron structure. Genome Res. 23(5), 789-799 (2013).
128. Maunakea AK, Chepelev I, Cui K, Zhao K. Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition. Cell Res. 23(11), 1256-1269 (2013).
129. Shukla S, Kavak E, Gregory M et al. CTCF-promoted RNA polymerase II pausing links DNA methylation to splicing. Nature 479(7371), 74-79 (2011).
130. Batsche E, Yaniv M, Muchardt C. The human SWI/SNF subunit Brm is a regulator of alternative splicing. Nat. Struct. Mol. Biol. 13(1), 22-29 (2006).
131. Zraly CB, Dingwall AK. The chromatin remodeling and mRNA splicing functions of the Brahma (SWI/SNF) complex are mediated by the SNR1/SNF5 regulatory subunit. Nucleic Acids Res. 40(13), 5975-5987 (2012).
132. Glaros S, Cirrincione GM, Muchardt C, Kleer CG, Michael CW, Reisman D. The reversible epigenetic silencing of BRM: implications for clinical targeted therapy. Oncogene 26(49), 7058-7066 (2007).
133. Gao X, Tate P, Hu P, Tjian R, Skarnes WC, Wang Z. ES cell pluripotency and germ-layer formation require the SWI/SNF chromatin remodeling component BAF250a. Proc. Natl Acad. Sci. USA 105(18), 6656-6661 (2008).
134. Lei I, Gao X, Sham MH, Wang Z. SWI/SNF protein component BAF250a regulates cardiac progenitor cell differentiation by modulating chromatin accessibility during second heart field development. J. Biol. Chem. 287(29), 24255-24262 (2012).
135. Bochar DA, Wang L, Beniya H et al. BRCA1 is associated with a human SWI/SNF-related complex: linking chromatin remodeling to breast cancer. Cell 102(2), 257-265 (2000).
136. Zhang L, Chen H, Gong M, Gong F. The chromatin remodeling protein BRG1 modulates BRCA1 response to UV irradiation by regulating ATR/ATM activation. Front. Oncol. doi:10.3389/fonc.2013.00007 (2013) (Epub ahead of print).
137. Wang J, Gu H, Lin H, Chi T. Essential roles of the chromatin remodeling factor BRG1 in spermatogenesis in mice. Biol. Reprod. 86(6), 186 (2012).